High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission.

High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission. Leukemia. 2000 Jul; 14(7):1191-6.

View in: PubMed

subject areas

Adult
Antineoplastic Combined Chemotherapy Protocols
Cerebellar Diseases
Chromosome Aberrations
Chromosome Deletion
Chromosome Inversion
Chromosomes, Human
Chromosomes, Human, Pair 7
Cytarabine
Daunorubicin
Female
Humans
Leukemia, Myeloid
Logistic Models
Male
Middle Aged
Prognosis
Remission Induction
Retrospective Studies
Sepsis
Translocation, Genetic
Treatment Outcome

authors with profiles

Daniel Arber